bromhexine has been researched along with Labor, Premature in 2 studies
Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective double-blind clinical trial was carried out to determine whether ambroxol (bromhexine metabolite VIII) treatment (1000 mg/day for a period of 5 days) reduces the risk of hyaline membrane disease (HMD) in potentially premature infants." | 9.05 | The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study. ( Böttcher, M; Fricke, U; Grauel, EL; Hinkel, GK; Jacobi, R; Koepke, E; Köppe, I; Kunze, D; Lachmann, B; Lampe, K; Menzel, K; Methfessel, G; Müller, K; Nitz, I; Plath, C; Reichmann, G; Schlegel, C; Schmalisch, G; Schmidt, W; Schröder, M; Severin, K; Sitka, U; Tiller, R; Wauer, RR, 1982) |
| "A prospective double-blind clinical trial was carried out to determine whether ambroxol (bromhexine metabolite VIII) treatment (1000 mg/day for a period of 5 days) reduces the risk of hyaline membrane disease (HMD) in potentially premature infants." | 5.05 | The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study. ( Böttcher, M; Fricke, U; Grauel, EL; Hinkel, GK; Jacobi, R; Koepke, E; Köppe, I; Kunze, D; Lachmann, B; Lampe, K; Menzel, K; Methfessel, G; Müller, K; Nitz, I; Plath, C; Reichmann, G; Schlegel, C; Schmalisch, G; Schmidt, W; Schröder, M; Severin, K; Sitka, U; Tiller, R; Wauer, RR, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wauer, RR | 1 |
| Schmalisch, G | 1 |
| Menzel, K | 1 |
| Schröder, M | 1 |
| Müller, K | 1 |
| Tiller, R | 1 |
| Methfessel, G | 1 |
| Sitka, U | 1 |
| Koepke, E | 1 |
| Plath, C | 1 |
| Schlegel, C | 1 |
| Böttcher, M | 1 |
| Köppe, I | 1 |
| Fricke, U | 1 |
| Severin, K | 1 |
| Jacobi, R | 1 |
| Schmidt, W | 1 |
| Hinkel, GK | 1 |
| Nitz, I | 1 |
| Kunze, D | 1 |
| Reichmann, G | 1 |
| Lachmann, B | 1 |
| Lampe, K | 1 |
| Grauel, EL | 1 |
| Merkus, JM | 1 |
| Roozen, PH | 1 |
| Verhoeven, AG | 1 |
| Kock, HC | 1 |
2 trials available for bromhexine and Labor, Premature
| Article | Year |
|---|---|
The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study.
Topics: Ambroxol; Amniotic Fluid; Bromhexine; Clinical Trials as Topic; Double-Blind Method; Female; Gestati | 1982 |
Surfactant in the amniotic fluid and bromhexine metabolite VIII.
Topics: Ambroxol; Amniotic Fluid; Bromhexine; Clinical Trials as Topic; Double-Blind Method; Female; Gestati | 1978 |